What Happened?
Oklahoma, OK-based Tetherex Pharmaceuticals Appointed Scott Rollins as President and Chief Executive Officer
About the Company
At Tetherex, we are committed to advancing the understanding of inflammation in various disease processes and developing novel products to treat inflammatory diseases, thrombosis and cancer. Our mission is focused on helping patients who suffer these afflictions enjoy better and longer lives. Our pioneering work on the molecular mechanisms of inflammation has led to breakthroughs in novel therapeutic candidates for inflammatory and thrombotic diseases and positioned Tetherex with strong scientific underpinnings. Our employees are committed to the highest standards of integrity and excellence in medical research.
About the Person
Scott Rollins is President and Chief Executive Officer at Tetherex Pharmaceuticals. Previously, Scott held various senior HR leadership roles in the industry.
Info Source
News
Short Profile